...
机译:ESRRG ESRRG促进剂高甲基化作为喉鳞状细胞癌中的诊断和预后生物标志物
Department of Otorhinolaryngology‐Head and Neck SurgeryLihuili Hospital of Ningbo UniversityNingbo;
Department of OtolaryngologyNingbo University Medical SchoolNingbo China;
Department of Otorhinolaryngology‐Head and Neck SurgeryLihuili Hospital of Ningbo UniversityNingbo;
Department of OtolaryngologyNingbo University Medical SchoolNingbo China;
Department of OtolaryngologyNingbo University Medical SchoolNingbo China;
Department of Otorhinolaryngology‐Head and Neck SurgeryLihuili Hospital of Ningbo UniversityNingbo;
Department of Otorhinolaryngology‐Head and Neck SurgeryLihuili Hospital of Ningbo UniversityNingbo;
Department of Otorhinolaryngology‐Head and Neck SurgeryLihuili Hospital of Ningbo UniversityNingbo;
diagnostics; DNA methylation; estrogen‐related receptor gamma; laryngeal squamous cell carcinoma; prognostics;
机译:ESRRG ESRRG促进剂高甲基化作为喉鳞状细胞癌中的诊断和预后生物标志物
机译:LZTS2启动子高甲基化:潜在的生物标志物,用于喉鳞状细胞癌的诊断和预后
机译:p16INK4A和p14ARF基因启动子高甲基化作为口腔和口咽鳞状细胞癌的预后生物标志物:综述
机译:鉴定用于食管鳞状细胞癌的RNA生物标志物
机译:MicroRNA-137启动子甲基化作为头颈部鳞状细胞癌的病因和预后生物标志物。
机译:SHISA3启动子甲基化是喉鳞状细胞癌的潜在诊断和预后生物标志物。
机译:SSTR2启动子高甲基化与男性喉鳞状细胞癌的风险和进展有关